In contrast, high DYRK1 expression increases ID2 Thr27 phosphorylation, leading to glioma stemness deficiency, which inhibits tumor growth and is more favorable to the prognosis of GBM patients.53 This evidence concerns the gene DYRK1A and neoplasm.